[
  {
    "ts": null,
    "headline": "The Play On Legend Biotech",
    "summary": "Legend Biotech faces a 60% stock drop amid safety, supply issues, and competition for its CAR-T therapy, Carvykti. See here for an analysis of LEGN stock.",
    "url": "https://finnhub.io/api/news?id=226b68a260ac6eef047dd63139b5a1dd6628fbc71f5c485d716cff41b6ab799e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746247887,
      "headline": "The Play On Legend Biotech",
      "id": 134215151,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1473708731/image_1473708731.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Legend Biotech faces a 60% stock drop amid safety, supply issues, and competition for its CAR-T therapy, Carvykti. See here for an analysis of LEGN stock.",
      "url": "https://finnhub.io/api/news?id=226b68a260ac6eef047dd63139b5a1dd6628fbc71f5c485d716cff41b6ab799e"
    }
  }
]